RAC1 Alterations Induce Acquired Dabrafenib Resistance in Association with Anaplastic Transformation in a Papillary Thyroid Cancer Patient
Rozita Bagheri‐Yarmand(The University of Texas MD Anderson Cancer Center), Marie‐Claude Hofmann(The University of Texas MD Anderson Cancer Center)
Cited by 30
Related Papers
Identification of Pax5 as a Target of MTA1 in B-Cell Lymphomas
|Cancer Research|2007|68
Review article: new treatments for advanced differentiated thyroid cancers and potential mechanisms of drug resistance
|Frontiers in Endocrinology|2023|49
Reimagining the Therapeutic Approach for Anaplastic Thyroid Cancer: The Roadmap to a Cure
|Thyroid|2025|5
Characterization of Advanced <i>RAS</i> -driven Follicular-derived Thyroid Cancers and Review of Future Therapeutic Avenues
|The Journal of Clinical Endocrinology & Metabolism|2025|5